Table 3 The baseline patient characteristics on day 0
Total | G group | I group | |
|---|---|---|---|
N | 60 | 35 | 25 |
Age, y | 73 (67, 78) | 73 (67, 78) | 71 (66, 78) |
Sex F/M | 16/44 | 12/23 | 4/21 |
Height, cm | 160 ± 10 | 162 (152.7, 167) | 161 (151.9, 168.7) |
Body weight, kg | 59.2 (50.7, 67.4) | 57.7 (49.7, 71.5) | 60.6 (54.3, 65.3) |
BMI | 23.3 (20.2, 25.9) | 23.6 (20.0, 26.0) | 22.9 (21.7, 25.6) |
eGFR, ml/min/1.73m2 | 21 (14, 29) | 20 (14, 34) | 21 (17, 28) |
Uric Acid, mg/dL | 7 (6.1, 7.5) | 7.2 (6.3, 7.6) | 6.6 (6, 7.4) |
SBP, mmHg | 130 (123, 146) | 129 (123, 140) | 138 (122, 148) |
Diabetes | 28 (47) | 16 (46) | 12 (48) |
Hypertension | 56 (93) | 33 (94) | 23 (92) |
Coronary artery disease | 9 (15) | 4 (11) | 5 (20) |
Use of diuretics | 25 (42) | 13 (37) | 12 (48) |
Use of UA-lowering medication | 44 (73) | 25 (71) | 19 (76) |
Estimated urinary Cr excretion, mg/day | 785 (650, 906) | 784 (589, 873) | 820 (672, 913) |
Estimated urinary Na excretion, mEq/day | 117.4 (106.0, 142.0) | 113.9 (101.1, 139.5) | 118.9 (114.4, 146.2) |